Generation of Isotype Switch Variants form Hybridoma cells Producing anti-Streptococcus penumoniae 6B Polysaccharide Antibody

  • Kim, Jihye (Faculty of Biological Sciences, Chonbuk National University, Chonju) ;
  • Eunja Ryu (Faculty of Biological Sciences, Chonbuk National University, Chonju) ;
  • Park, Moon-Kook (Faculty of Biological Sciences, Chonbuk National University, Chonju)
  • Published : 1999.09.01

Abstract

hybridoma cells producing IgM anti-pneuococcal 6B polysaccharide antibodies were induced to switch to IgG-producing cells in vitro by treating with acridine orange. Treating 0.5 $\mu\textrm{g}$/ml of acridine orange for 24 hours generated maximal number of variant cells. The maximal isotype switch frequency was 3${\times}$10-5, which is about 30-fold higher than the frequency of spontaneous switching. Resulting IgG-producing variants were enriched by sib selection and ELISA spot assay. Two IgG3-producing variant cells were finally cloned by limiting dilution. The variant cells produced similar amounts of antibodies as their parental cells did. The two switched antibodies had similar reactivity to pneumococcal 6B polysaccharide. When compared to their parental IgM antibodies, the switched IgG3 than that of IgM antibody. The antibodies will be useful as essential tools for comparative study of the role of heavy chain isotypes in protection against Streptococcus pneumoniae.

Keywords

References

  1. J. Amer. Med. Assoc. v.271 Emergence of drug-resistant pneumococcal infections in the United States Breiman, R.F.;J.C. Butler;F.C. Tenover;J.A. Elliott;R.R. Facklam
  2. Clin. Infect. Dis. v.14 Mechanism of host defense against infection with Streptococcus pneumoniae Bruyn, G.A.W.;B.J.W. Zegers;R. van Furth
  3. J. Exp. Med. v.170 Transforming growth factor specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes Coffman, R.L.;D.A. Lebman;B. Shrader
  4. J. Infect. Diseases v.167 Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media Giebink, G.S.;M. Koskela;P. Vella;M. Harris;C.T. Le
  5. J. Microbiol. v.36 Human antibody responses to capsular polysaccharides of Streptococcus pneumoniae 6B. 14, and 19F Kim, J.H.;K.H. Kim;J.S. Kim;J.H. Song;M.K. Park
  6. Molecular and clinical aspects of bacterial vaccine development Vaccines against Streptococcus pneumoniae Mitchell, T.J.;P.W. Andrew;D.A.A. Ala'Aldeenand C.E. Hormaeche(ed.)
  7. Hybridoma v.14 Use of mutagens to increase rate of immunoglobulin isotype switching of hybridoma cells Paizi, M;D. Zivion;G. Spira
  8. Science v.265 Pneumococcal disease: prospects for a new generation of vaccines Siber, G.R.
  9. Immunol. Rev. v.102 Regulation of IgG1 and IgE production by interleukin 4 Snapper, C.M.;F.D. Finkelman;W.E. Paul
  10. J. Immunol. Methods v.74 The identification of monoclonal class switch variants by sib selection and an ELISA assay Spira G.;A. Bagellesi;J-L. Teillaud;M.D. Scharff
  11. J. Immunol. Methods v.148 Identification of rare immunoglobulin switch variants using the ELISA spot assay Spira G.;M. D. Scharff
  12. Clin. Exp. Immunol. v.105 Generation of biologically active anti-Cryptococcus neoformis IgG, IgE, and IgA isotype switch variant antibodies by acridine orange mutagenesis Spira G.;M. Paizi;S. Mazar;G. Nussbaum;S. Mukherjee;A. Casadevall
  13. Immunol. Rev. v.102 T cell replacing factor (TRF) interleukin 5 (IL-5): Molecular and functional properties Takutsu, C.M.;A. Harada;S. Mita;M. Matsumoto;O. Takahashi;Y. Kikuchi;N. Yamaguchi
  14. Int. Immunol. v.3 Ig isotype switching in B lymphocyte. The effect of T cell derived interleukins, cytokines, cholera toxin and antigen on isotype switch frequency of a cloned B cell lymphoma Whitmore, A.C.;D.M., Praise;G. Haughton;L.W. Arnold